Literature DB >> 169126

Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.

S J Marx, G D Aurbach.   

Abstract

High affinity binding of 125I-labeled salmon calcitonin ([125I]SCT) and calcitonin-activated adenylate cyclase were detectable in renal plasma membranes from the rat. Addition of 5'-guanylyl-imidodiphosphate lowered the threshold for enzyme activation by peptide hormones. Renal plasma membranes from man, dog and cow contained little or no calcitonin-sensitive adenylate cyclase and showed no high affinity binding of [125I]SCT. High affinity binding sites were distributed during membrane fractionation in fractions where the specific activity of hormone-sensitive adenylate cyclase was greatest. Calcitonin binding and activation of the adenylate cyclase enzyme occurred at similar hormone concentrations. The relative potencies of calcitonin analogues were similar whether measured by competition for high affinity binding sites or by effect on adenylate cyclase. Low concentrations of Lubrol-PX, a nonionic detergent, did not affect catalytic function of the enzyme determined in the presence of sodium fluoride but caused parallel loss of high affinity [125I]SCT binding and hormonal sensitivity of the enzyme. This observation provided further evidence that interaction of calcitonin with specific receptors (identified with [125I]SCT binding) is essential for calcitonin activation of adenylate cyclase, but showed that catalytic activity of enzyme does not require functioning hormone receptors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169126     DOI: 10.1210/endo-97-2-448

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Distribution of calcitonin-sensitive adenylate cyclase activity along the rabbit kidney tubule.

Authors:  D Chabardès; M Imbert-Teboul; M Montégut; A Clique; F Morel
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

2.  Infusion of zinc inhibits serum calcitonin levels in patients with various zinc status.

Authors:  S Nishiyama; T Nakamura; A Higashi; I Matsuda
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

3.  Effects of calcitonin on human auditory and visual evoked brain potentials.

Authors:  R Pietrowsky; M Dentler; H L Fehm; J Born
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Effects of ketoprofen on the calciuric and uricosuric activities of calcitonin in man.

Authors:  C E Fiore; A Petralito; M C Mazzarino; A Liuzzo; G Malaponte; R A Mangiafico; S Gibiino
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

5.  Extraction of a substance with calcitonin-like immunoreactivity from pituitary glands of intact and thyroidectomized rats.

Authors:  H G Bone; B D Catherwood; L J Deftos
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

6.  Tumour calcitonin. Interaction with specific calcitonin receptors.

Authors:  J Ham; M L Ellison; J Lumsden
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

7.  Immunohistochemical localization of 3':5'-cyclic AMP and 3':5'-cyclic GMP in rat renal cortex: effect of parathyroid hormone.

Authors:  T P Dousa; L D Barnes; S H Ong; A L Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

8.  Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin.

Authors:  S Iida; S Kakudo; Y Mori; M Matsui; K Magota; Y Kitajima; N Nakamura; H Mano; Y Hakeda; H Azuma; T Kurokawa; M Kumegawa
Journal:  Calcif Tissue Int       Date:  1996-08       Impact factor: 4.333

9.  Salmon calcitonin and cGMP production by human kidney: studies in vivo and in vitro.

Authors:  C Gennari; R Toccafondi; C M Rotella; G Francini; M L Brandi; E Maioli
Journal:  Calcif Tissue Int       Date:  1983-05       Impact factor: 4.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.